& Dosage | Action
| Interactions |Adverse
Effects & Precautions |
Brands available in Market
After administration it has a short plama half life.
UNDER FULL OBSTETRIC SUPERVISION TO SHORTEN THIRD STAGE OF LABOR FOLLOWING DELIVER OF ANTERIOR SHOULDER; ROUTINE MANAGEMENT AFTER DELIVERY OF PLACENTA; POSTPARTUM OR POSTABORTAL ATONY & HEMORRHAGE: 0.2mg IM; may be repeated as reqd, at intervals of 2-4 hrs. IV use is not routinely advocated unless as an emergency measure. IV DOSE SAME AS IM DOSE.
MILD POSTPARTUM HEMORRHAGE; UTERINE SUBINVOLUTION: 0.2mg t.i.d/q.i.d. in the pureperuim for a maximum of one week.
Selective stimulant on uterine muscle especially towards term, during labour and postpartum. Sensitivity of the uterus to oxytocin increases throughout the pregnancy reaching the maximum at term.
Sympathomimetics: Pressor effect of sympathomimetics may be increased leading to postpartum hypertension.
Prostaglandins: Risk of uterine rupture and cerival lacerations.
Ergotamine: Synergistic effect in control of post partum hemorrhage.
Adverse Effect &
Inj: Tachycardia, hypotension, ECG changes water intoxication.
Precaution: I.V. Infusion to be given under close medical supervision and careful monitoring of the patient is to be done, cardiovascular disorders, hypersensitivity.